<DOC>
	<DOCNO>NCT01489982</DOCNO>
	<brief_summary>More half patient Parkinson 's trouble insomnia . There several treatment option insomnia study general population - however , investigator n't know treatment work patient Parkinson 's . It possible people Parkinson 's may different treatment response . The goal project test pilot study tolerability effectiveness pharmacologic non-pharmacologic treatment improve insomnia patient Parkinson 's disease . Each participant study wear wrist actigrapch fill sleep diary . Three main treatment strategy test : Placebo Light therapy , Cognitive behavioural therapy active light therapy , insomnia medication . The treatment person receive first chosen randomly . If first therapy effective , participant may choose re-enrol trial one remain two therapy .</brief_summary>
	<brief_title>Treatments Insomnia Patients With Parkinson 's Disease</brief_title>
	<detailed_description>There variety treatment help manage insomnia , include non-pharmacological pharmacologic measure . Although many strategy proven effective general population study conduct Parkinson 's Disease ( PD ) patient . Insomnia PD unique characteristic pathophysiology ; therefore , measure treat insomnia general population may ineffective PD . The goal project test pilot study tolerability effectiveness pharmacologic non-pharmacologic treatment improve insomnia patient Parkinson 's disease . Participants come four visit : screening , 1 week , 3 week 7 week . Study visit take approximately 1.5 2 hour . During entire period study , participant wear wrist actigraph - motion sense device size wristwatch . Specific instruction use device use sleep diary explain first visit . Participant also fill sleep diary every day , keep track many hour sleep , etc . During study visit in-depth interview , researcher review participant sleep diary troubleshoot problem . In trial investigator test three main treatment strategy . The treatment patient receive first chosen randomly - essential properly test strategy . Participant know group he/she assign . If first therapy effective patient , he/she may choose re-enroll trial , case participant receive one remain two therapy . The therapy : 1 . Light therapy , patient use 30 minute , start two hour ( +/- 1 hour ) usual bedtime . Light box provide team . Patient instructed use light . 2 . Cognitive behavioural therapy sleep hygiene train - This involve education sleep general , give technique relate sleep relaxation , tip stress management , etc.. This take place Lady Davis Institute Jewish General Hospital . There 6 weekly session total 90 minute - time group set , maximum 6 patient per group . Light therapy also part treatment strategy . 3 . Insomnia medication - In portion patient receive medication help sleep . Depending type patient 's sleep problem , either medication call desipramine ( also call Doxepin ) , zopiclone ( also call Imovane ) . Both medication currently use insomnia people without Parkinson 's . These medication prescribe exactly medical prescription , participant take medical prescription .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zopiclone</mesh_term>
	<mesh_term>Doxepin</mesh_term>
	<criteria>All patient recruit Movement Disorder Clinics McGill University Health Center . Patients eligible inclusion diagnosis idiopathic PD suffer insomnia , define SCOPAsleep nocturnal subscore &gt; 7 . The insomnia must persistent least 6 month ( patient selfreport ) . The subject must speak either English French sufficiently fill questionnaire . 1 . Use sedative medication night ( include sedate antidepressant ) . Patients may take nonsedating antidepressant dose stable 1 month . 2 . Untreated restless legs syndrome , night shift work , occupational cause abnormal sleep pattern , reversible cause insomnia detect upon baseline clinical interview . If treatment potentiallyreversible cause unsuccessful insomnia persistent &gt; 3 month follow treatment initiation , patient enrol . 3 . Insomnia secondary suboptimal dopaminergic therapy . If change dopaminergic therapy require clinical interview , patient still eligible inclusion insomnia persistent &gt; 3 month . 4 . Premenopausal woman use effective method birth control ( note small minority woman PD premenopausal , effect exclusion criterion create gender imbalance minimal ) . 5 . Dementia , define accord PD dementia criterion MMSE &lt; 26/30 ADL impairment secondary cognitive loss , inability understand consent process . 6 . Change dopaminergic therapy precede three month . 7 . Patients severe PD , define Hoehn Yahr 5 ( i.e . nonambulatory ) . Provision sleep hygiene measure , etiology insomnia , potential confounds interpretation actigraphy immobile patient problematic advanced stage PD . 8 . Insomnia relate untreated moderatesevere depression anxiety . Beck depression score &gt; 20i.e , moderate depression ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>insomnia</keyword>
</DOC>